Trials / Completed
CompletedNCT03804554
A Study of Participants in Australia Who Have Non-small Cell Lung Cancer Being Treated With Nivolumab
Nivolumab in the Treatment of Patients With Non-small Cell Lung Cancer: The Australian Experience
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 503 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is to capture and describe the patient and disease characteristics and the outcomes of adult patients with previously-treated advanced NSCLC who have been treated with Nivolumab
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional | Non-Interventional |
Timeline
- Start date
- 2018-10-03
- Primary completion
- 2021-08-12
- Completion
- 2021-08-12
- First posted
- 2019-01-15
- Last updated
- 2022-05-27
Locations
1 site across 1 country: Australia
Source: ClinicalTrials.gov record NCT03804554. Inclusion in this directory is not an endorsement.